MediWound (MDWD) Consolidated Net Income (2013 - 2025)
MediWound's (MDWD) quarterly Consolidated Net Income came in at -$7.7 million in Q4 2025, down 27.03% year-on-year from -$10.6 million in Q4 2024, and down 19.39% quarter-over-quarter from -$6.5 million in Q3 2025.
MediWound (MDWD) Consolidated Net Income (2013 - 2025) Analysis & Trends
MediWound's Consolidated Net Income history runs 13 years deep, the most recent figure standing at -$7.7 million for Q4 2025.
- On a quarterly basis, Consolidated Net Income fell 27.03% year-over-year to -$7.7 million in Q4 2025; TTM through Dec 2025 was -$32.7 million, a 54.34% decrease from a year earlier, with the FY2025 full-year figure at -$23.7 million, up 21.31% from the prior year.
- Consolidated Net Income slipped to -$7.7 million in Q4 2025 per MDWD's latest filing, from -$6.5 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $940000.0 in Q2 2023 and bottomed at -$13.2 million in Q2 2025.
- The 5-year median for Consolidated Net Income is -$4.2 million (2022), against an average of -$4.7 million.
- Across the five-year window, Consolidated Net Income tumbled 138500.0% in 2021 and soared 121.63% in 2023, its largest moves.
- Year by year, Consolidated Net Income stood at -$4.2 million in 2021, then slumped by 76.47% to -$7.3 million in 2022, then jumped by 79.49% to -$1.5 million in 2023, then tumbled by 304.72% to -$6.1 million in 2024, then slipped by 27.03% to -$7.7 million in 2025.
- Per Business Quant, the three latest MDWD Consolidated Net Income figures stand at -$7.7 million (Q4 2025), -$6.5 million (Q3 2025), and -$13.2 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,880.51 Bn | 1,880.45 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 467.94 Bn | 463.15 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 122.63 Bn | 115.38 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.54 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.81 Bn | 62.81 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 55.78 Bn | 50.59 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn | 205.99 Mn |
| 10 | MediWound | 167.24 Mn | 162.44 Mn | 278,000.00 | -7.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.73 Mn |
| Sep 30, 2025 | -6.47 Mn |
| Jun 30, 2025 | -13.24 Mn |
| Mar 31, 2025 | -5.22 Mn |
| Dec 31, 2024 | -6.08 Mn |
| Sep 30, 2024 | -5.06 Mn |
| Jun 30, 2024 | -6.31 Mn |
| Mar 31, 2024 | -3.71 Mn |
| Dec 31, 2023 | -1.50 Mn |
| Sep 30, 2023 | -2.10 Mn |
| Jun 30, 2023 | 940,000.00 |
| Mar 31, 2023 | -3.68 Mn |
| Dec 31, 2022 | -7.33 Mn |
| Sep 30, 2022 | -4.19 Mn |
| Jun 30, 2022 | -4.35 Mn |
| Mar 31, 2022 | -3.58 Mn |
| Dec 31, 2021 | -4.15 Mn |
| Sep 30, 2021 | -3.34 Mn |
| Mar 31, 2021 | -2.85 Mn |
| Dec 31, 2020 | 3,000.00 |